INTERNATIONAL-DRUG-DEVELOPMENT-BIOTECH
6Patents
6Active
6Granted
48Portfolio score
Filing activity: Jul 18, 2011 → Nov 24, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9120856B2 | Anti-CD19 antibody having ADCC function with improved glycosylation profile | Chemistry; Metallurgy | 3 | Active |
| US10533046B2 | Anti-CK8 antibodies for use in the treatment of colorectal cancers | Physics | 1 | Active |
| USRE49192E1 | Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation profile | General | 1 | Active |
| US9663583B2 | Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation profile | Chemistry; Metallurgy | 1 | Active |
| US12077597B2 | Anti-CD5 antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11634488B2 | Treatment of B cell malignancies using afucosylated pro-apoptotic anti-CD19 antibodies in combination with anti CD20 antibodies or chemotherapeutics | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.